Linomide and antibody-targeted superantigen therapy abolishes formation of liver metastases in mice.

Liu, Q; Klintman, D; Corbascio, M; Ekberg, H; Hedlund, G; Forsberg, G; Thorlacius, H

Liu, Q; Klintman, D; Corbascio, M; Ekberg, H; Hedlund, G; Forsberg, G; Thorlacius, H.

Affiliation

Liu Q; Department of Surgery, Malmö University Hospital, Lund University, Malmö, Sweden.

Eur Surg Res ; 35(6): 457-63, 2003.

Article in En | MEDLINE | ID: mdl-14593228

Subject(s)

Adjuvants, Immunologic/pharmacology; Hydroxyquinolines/pharmacology; Liver Neoplasms/drug therapy; Liver Neoplasms/prevention & control; Lymphocyte Function-Associated Antigen-1/genetics; Animals; Cell Line, Tumor; Colonic Neoplasms/pathology; Humans; Immunoglobulin Fab Fragments/genetics; Immunotherapy; Liver Neoplasms/secondary; Lymphocyte Function-Associated Antigen-1/immunology; Male; Melanoma; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Recombinant Fusion Proteins/pharmacology; Superantigens/immunology; Xenograft Model Antitumor Assays

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Adjuvants, Immunologic / Lymphocyte Function-Associated Antigen-1 / Hydroxyquinolines / Liver Neoplasms Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Eur Surg Res Year: 2003 Document type: Article Affiliation country: Sweden Country of publication: Switzerland

Search on Google

Add to My VHL

XML

PubMed Links